The Provider Network Strategy Lie: Why Health Plans Still Can’t Control Cost in 2026
For over a decade, value-based care (VBC) has been positioned as the solution to rising healthcare costs and inconsistent outcomes. Yet in 2026, most health plans are confronting a difficult reality: while VBC improved quality metrics in targeted areas, it has not consistently reduced total cost of care—particularly across medical and pharmacy spend.
The issue isn’t the concept. It’s design and execution.
Where Health Plans Are Actually Spending
Cost pressure is no longer diffuse—it’s concentrated and predictable:
-
Hospital spend (40–45%)
Avoidable admissions, site-of-care leakage, and inefficient post-acute transitions continue to drive unnecessary cost. -
Hospital spend (40–45%)
Pharmacy (25–30%)GLP-1s, specialty drugs, oncology therapies, and gene-based treatments are outpacing every other category. -
Hospital spend (40–45%)
Specialty care (20%)Fragmented referrals and limited accountability models are fueling overutilization. -
Hospital spend (40–45%)
Post-acute & ancillary (10–15%)Significant variation across SNFs, home health, and MSK pathways remains unchecked.
Despite years of innovation, most plans still lack control over the full continuum of care decisions—where cost is actually created.
Why Value-Based Care Missed the Mark
VBC largely focused on primary care attribution. But primary care alone does not control:
- Specialist decision-making
- High-cost drug utilization
- Site-of-care selection
- Referral leakage
The result? Plans optimized pieces of the system, while the most expensive levers remained unmanaged.
The Shift: From Networks to Performance Ecosystems
Health plans don’t need incremental network improvements—they need a fundamental redesign of how networks are built, governed, and activated.
-
From Broad Access to Precision Networks
The era of “everyone in-network” is over. High-performing plans are:
- Tiering providers based on total cost of care and outcomes—not just discounts
- Designing population-specific networks (MA, Medicaid, ACA) with curated, high-value providers
-
Specialist & Pharmacy Accountability—Finally
Cost cannot be controlled without addressing its biggest drivers:
- Embedding specialty pathways (oncology, cardiology, MSK) with utilization and cost accountability
- Integrating pharmacy management into provider contracts, not managing it as a silo
-
Site-of-Care as a Strategic Lever
Where care happens is as important as what care is delivered:
- Shifting volume to ambulatory surgery centers (ASCs), home-based care, and virtual-first models
- Moving away from fee-for-service hospital dependence toward risk-aligned partnerships
-
From Static Contracts to Dynamic Control Towers
Annual contracts don’t drive daily behavior. Execution does.
- Leading plans are building real-time performance control towers
- Tracking referrals, admissions, prescribing patterns, and leakage as they happen Enforcing performance with active management—not retrospective reporting
Despite years of innovation, most plans still lack control over the full continuum of care decisions—where cost is actually created.
Where It’s Working
There are clear signals across the market:
- In Minnesota, organizations like HealthPartners demonstrate what’s possible when payer-provider alignment is tightly integrated across primary and specialty care. Tragically health plans are still losing money in MN.
- In California, models like Kaiser Permanente show the power of full-risk, closed-loop delivery systems.
- In Massachusetts, global budget models are proving that accountability across the continuum can stabilize cost trends.
These markets succeed because they align incentives, control the full care journey, and operationalize performance daily.
The HLTHWorks Perspective
Health plans don’t have a value-based care problem—they have an execution problem.
The future of network management is not contracting. It’s orchestration.
Plans that win will:
- Curate networks with precision
- Hold specialists and pharmacy accountable
- Redesign site-of-care economics
- Operate with real-time performance visibility
Everything else will continue to deliver incremental gains—while costs accelerate.